GSK Current Ratio 2010-2023 | GSK
Current and historical current ratio for GSK (GSK) from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. GSK current ratio for the three months ending March 31, 2023 was 0.95.
| GSK Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2023-03-31 |
$23.96B |
$25.14B |
0.95 |
| 2022-12-31 |
$25.69B |
$28.21B |
0.91 |
| 2022-09-30 |
$23.85B |
$24.68B |
0.97 |
| 2022-06-30 |
$68.03B |
$47.50B |
1.43 |
| 2022-03-31 |
$38.90B |
$32.58B |
1.19 |
| 2021-12-31 |
$25.68B |
$32.55B |
0.79 |
| 2021-09-30 |
$25.17B |
$30.91B |
0.81 |
| 2021-06-30 |
$24.55B |
$29.90B |
0.82 |
| 2021-03-31 |
$25.55B |
$27.96B |
0.91 |
| 2020-12-31 |
$26.00B |
$28.44B |
0.91 |
| 2020-09-30 |
$25.68B |
$28.65B |
0.90 |
| 2020-06-30 |
$28.51B |
$29.69B |
0.96 |
| 2020-03-31 |
$28.21B |
$32.45B |
0.87 |
| 2019-12-31 |
$24.89B |
$30.71B |
0.81 |
| 2019-09-30 |
$25.88B |
$31.46B |
0.82 |
| 2019-06-30 |
$23.44B |
$33.14B |
0.71 |
| 2019-03-31 |
$22.83B |
$31.86B |
0.72 |
| 2018-12-31 |
$22.59B |
$30.02B |
0.75 |
| 2018-09-30 |
$22.70B |
$23.97B |
0.95 |
| 2018-06-30 |
$23.20B |
$24.77B |
0.94 |
| 2018-03-31 |
$22.85B |
$37.47B |
0.61 |
| 2017-12-31 |
$20.50B |
$34.24B |
0.60 |
| 2017-09-30 |
$23.12B |
$35.92B |
0.64 |
| 2017-06-30 |
$21.01B |
$36.81B |
0.57 |
| 2017-03-31 |
$20.79B |
$23.23B |
0.90 |
| 2016-12-31 |
$22.65B |
$25.75B |
0.88 |
| 2016-09-30 |
$23.13B |
$23.82B |
0.97 |
| 2016-06-30 |
$24.22B |
$25.98B |
0.93 |
| 2016-03-31 |
$22.68B |
$19.94B |
1.14 |
| 2015-12-31 |
$25.36B |
$20.52B |
1.24 |
| 2015-09-30 |
$26.33B |
$19.77B |
1.33 |
| 2015-06-30 |
$27.75B |
$21.13B |
1.31 |
| 2015-03-31 |
$31.63B |
$23.93B |
1.32 |
| 2014-12-31 |
$24.19B |
$21.91B |
1.10 |
| 2014-09-30 |
$24.83B |
$25.52B |
0.97 |
| 2014-06-30 |
$22.81B |
$20.62B |
1.11 |
| 2014-03-31 |
$21.92B |
$19.31B |
1.14 |
| 2013-12-31 |
$23.83B |
$21.40B |
1.11 |
| 2013-09-30 |
$20.88B |
$19.89B |
1.05 |
| 2013-06-30 |
$20.64B |
$19.17B |
1.08 |
| 2013-03-31 |
$21.93B |
$18.66B |
1.18 |
| 2012-12-31 |
$21.70B |
$21.90B |
0.99 |
| 2012-09-30 |
$21.32B |
$22.06B |
0.97 |
| 2012-06-30 |
$27.34B |
$24.39B |
1.12 |
| 2012-03-31 |
$25.57B |
$22.83B |
1.12 |
| 2011-12-31 |
$25.94B |
$24.08B |
1.08 |
| 2011-09-30 |
$26.43B |
$21.13B |
1.25 |
| 2011-06-30 |
$26.62B |
$22.23B |
1.20 |
| 2011-03-31 |
$26.90B |
$20.99B |
1.28 |
| 2010-12-31 |
$24.80B |
$19.51B |
1.27 |
| 2010-09-30 |
$26.03B |
$17.42B |
1.49 |
| 2010-06-30 |
$25.48B |
$17.91B |
1.42 |
| 2010-03-31 |
$28.66B |
$18.98B |
1.51 |
| 2009-12-31 |
$27.51B |
$18.98B |
1.45 |
| 2009-09-30 |
$28.47B |
$18.26B |
1.56 |
| 2009-06-30 |
$23.61B |
$13.99B |
1.69 |
| 2009-03-31 |
$24.40B |
$14.02B |
1.74 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$71.170B |
$36.279B |
|
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
|
